The company conducts research, development, manufacturing, direct and indirect sales, marketing and licensing of pharmaceuticals and medtech products. NBMI Science has orphan drug designation for the prevention and treatment of mercury toxicity.
NBMI Science
NBMI Science is a bio-technology firm developing metal chelator and anti oxidant NBMI (Irminix).
